{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:46:15Z","timestamp":1793832375114,"version":"4.6.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-22266-x","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T08:48:09Z","timestamp":1762159689000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The periodontal pathogen Fusobacterium nucleatum is associated with disease severity in multiple sclerosis"],"prefix":"10.1038","volume":"15","author":[{"given":"Hiroyuki","family":"Naito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Nakamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Nishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Toko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Muguruma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetada","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takamichi","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhide","family":"Ochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"key":"22266_CR1","doi-asserted-by":"publisher","first-page":"104696","DOI":"10.1016\/j.msard.2023.104696","volume":"73","author":"H Houzen","year":"2023","unstructured":"Houzen, H., Kano, T., Kondo, K., Takahashi, T. & Niino, M. The prevalence and incidence of multiple sclerosis over the past 20 years in Northern Japan. Mult Scler. Relat. Disord. 73, 104696. https:\/\/doi.org\/10.1016\/j.msard.2023.104696 (2023).","journal-title":"Mult Scler. Relat. Disord"},{"key":"22266_CR2","doi-asserted-by":"publisher","first-page":"e0137429","DOI":"10.1371\/journal.pone.0137429","volume":"10","author":"S Miyake","year":"2015","unstructured":"Miyake, S. et al. Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to clostridia XIVa and IV clusters. PLoS One. 10, e0137429. https:\/\/doi.org\/10.1371\/journal.pone.0137429 (2015).","journal-title":"PLoS One"},{"key":"22266_CR3","doi-asserted-by":"publisher","first-page":"22402","DOI":"10.1073\/pnas.2011703117","volume":"117","author":"D Takewaki","year":"2020","unstructured":"Takewaki, D. et al. Alterations of the gut ecological and functional microenvironment in different stages of multiple sclerosis. Proc. Natl. Acad. Sci. U S A. 117, 22402\u201322412. https:\/\/doi.org\/10.1073\/pnas.2011703117 (2020).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"22266_CR4","doi-asserted-by":"publisher","first-page":"810008","DOI":"10.3389\/fpsyt.2022.810008","volume":"13","author":"GB Bowland","year":"2022","unstructured":"Bowland, G. B. & Weyrich, L. S. The oral-microbiome-brain axis and neuropsychiatric disorders: an anthropological perspective. Front. Psychiatry. 13, 810008. https:\/\/doi.org\/10.3389\/fpsyt.2022.810008 (2022).","journal-title":"Front. Psychiatry"},{"key":"22266_CR5","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1016\/S0140-6736(05)67728-8","volume":"366","author":"BL Pihlstrom","year":"2005","unstructured":"Pihlstrom, B. L., Michalowicz, B. S. & Johnson, N. W. Periodontal diseases. Lancet 366, 1809\u20131820. https:\/\/doi.org\/10.1016\/S0140-6736(05)67728-8 (2005).","journal-title":"Lancet"},{"key":"22266_CR6","first-page":"686","volume":"83","author":"PE Petersen","year":"2005","unstructured":"Petersen, P. E., Bourgeois, D., Bratthall, D. & Ogawa, H. Oral health information systems\u2013towards measuring progress in oral health promotion and disease prevention. Bull. World Health Organ. 83, 686\u2013693 (2005). https:\/\/iris.who.int\/handle\/10665\/269479","journal-title":"Bull. World Health Organ."},{"key":"22266_CR7","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41577-020-00488-6","volume":"21","author":"G Hajishengallis","year":"2021","unstructured":"Hajishengallis, G. & Chavakis, T. Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities. Nat. Rev. Immunol. 21, 426\u2013440. https:\/\/doi.org\/10.1038\/s41577-020-00488-6 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"22266_CR8","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13195-017-0282-6","volume":"9","author":"CK Chen","year":"2017","unstructured":"Chen, C. K., Wu, Y. T. & Chang, Y. C. Association between chronic periodontitis and the risk of alzheimer\u2019s disease: a retrospective, population-based, matched-cohort study. Alzheimers Res. Ther. 9, 56. https:\/\/doi.org\/10.1186\/s13195-017-0282-6 (2017).","journal-title":"Alzheimers Res. Ther."},{"key":"22266_CR9","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/cei.13430","volume":"200","author":"H Nishi","year":"2020","unstructured":"Nishi, H. et al. Serum Immunoglobulin G antibody titer to Fusobacterium nucleatum is associated with unfavorable outcome after stroke. Clin. Exp. Immunol. 200, 302\u2013309. https:\/\/doi.org\/10.1111\/cei.13430 (2020).","journal-title":"Clin. Exp. Immunol."},{"key":"22266_CR10","doi-asserted-by":"publisher","first-page":"e0237185","DOI":"10.1371\/journal.pone.0237185","volume":"15","author":"S Aoki","year":"2020","unstructured":"Aoki, S. et al. Serum IgG titers to periodontal pathogens predict 3-month outcome in ischemic stroke patients. PLoS One. 15, e0237185. https:\/\/doi.org\/10.1371\/journal.pone.0237185 (2020).","journal-title":"PLoS One"},{"key":"22266_CR11","doi-asserted-by":"publisher","first-page":"e0241205","DOI":"10.1371\/journal.pone.0241205","volume":"15","author":"M Nakamori","year":"2020","unstructured":"Nakamori, M. et al. Serum IgG titers against periodontal pathogens are associated with cerebral hemorrhage growth and 3-month outcome. PLoS One. 15, e0241205. https:\/\/doi.org\/10.1371\/journal.pone.0241205 (2020).","journal-title":"PLoS One"},{"key":"22266_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.berh.2017.08.001","volume":"31","author":"Z Cheng","year":"2017","unstructured":"Cheng, Z., Meade, J., Mankia, K., Emery, P. & Devine, D. A. Periodontal disease and periodontal bacteria as triggers for rheumatoid arthritis. Best Pract. Res. Clin. Rheumatol. 31, 19\u201330. https:\/\/doi.org\/10.1016\/j.berh.2017.08.001 (2017).","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"22266_CR13","doi-asserted-by":"publisher","first-page":"e0260384","DOI":"10.1371\/journal.pone.0260384","volume":"16","author":"Z Zangeneh","year":"2021","unstructured":"Zangeneh, Z., Abdi-Ali, A., Khamooshian, K., Alvandi, A. & Abiri, R. Bacterial variation in the oral microbiota in multiple sclerosis patients. PLoS One. 16, e0260384. https:\/\/doi.org\/10.1371\/journal.pone.0260384 (2021).","journal-title":"PLoS One"},{"key":"22266_CR14","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1111\/ene.12103","volume":"20","author":"JJ Sheu","year":"2013","unstructured":"Sheu, J. J. & Lin, H. C. Association between multiple sclerosis and chronic periodontitis: a population-based pilot study. Eur. J. Neurol. 20, 1053\u20131059. https:\/\/doi.org\/10.1111\/ene.12103 (2013).","journal-title":"Eur. J. Neurol."},{"key":"22266_CR15","doi-asserted-by":"publisher","unstructured":"Tsimpiris, A. et al. Association of chronic periodontitis with multiple sclerosis: A systematic review and meta-analysis. Mult Scler Relat Disord 77, 104874 (2023). https:\/\/doi.org\/10.1016\/j.msard.2023.104874Get rights and content.","DOI":"10.1016\/j.msard.2023.104874Get"},{"key":"22266_CR16","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/nri3785","volume":"15","author":"G Hajishengallis","year":"2015","unstructured":"Hajishengallis, G. Periodontitis: from microbial immune subversion to systemic inflammation. Nat. Rev. Immunol. 15, 30\u201344. https:\/\/doi.org\/10.1038\/nri3785 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"22266_CR17","doi-asserted-by":"publisher","first-page":"e53653","DOI":"10.1371\/journal.pone.0053653","volume":"8","author":"AN McCoy","year":"2013","unstructured":"McCoy, A. N. et al. Fusobacterium is associated with colorectal adenomas. PLoS One. 8, e53653. https:\/\/doi.org\/10.1371\/journal.pone.0053653 (2013).","journal-title":"PLoS One"},{"key":"22266_CR18","doi-asserted-by":"publisher","first-page":"798685","DOI":"10.3389\/fmicb.2022.798685","volume":"13","author":"J Zhou","year":"2022","unstructured":"Zhou, J., Liu, L., Wu, P., Zhao, L. & Wu, Y. Fusobacterium nucleatum accelerates atherosclerosis via Macrophage-Driven aberrant Proinflammatory response and lipid metabolism. Front. Microbiol. 13, 798685. https:\/\/doi.org\/10.3389\/fmicb.2022.798685 (2022).","journal-title":"Front. Microbiol."},{"key":"22266_CR19","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.chom.2023.03.018","volume":"31","author":"M Hong","year":"2023","unstructured":"Hong, M. et al. Fusobacterium nucleatum aggravates rheumatoid arthritis through FadA-containing outer membrane vesicles. Cell. Host Microbe. 31, 798\u2013810. https:\/\/doi.org\/10.1016\/j.chom.2023.03.018 (2023). e7.","journal-title":"Cell. Host Microbe"},{"key":"22266_CR20","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s40035-021-00273-y","volume":"10","author":"HS Kim","year":"2021","unstructured":"Kim, H. S. et al. Gram-negative bacteria and their lipopolysaccharides in alzheimer\u2019s disease: pathologic roles and therapeutic implications. Transl Neurodegener. 10, 49. https:\/\/doi.org\/10.1186\/s40035-021-00273-y (2021).","journal-title":"Transl Neurodegener"},{"key":"22266_CR21","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke, J. F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33, 1444\u20131452. https:\/\/doi.org\/10.1212\/WNL.33.11.1444 (1983).","journal-title":"Neurology"},{"key":"22266_CR22","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41582-019-0170-8","volume":"15","author":"D Rotstein","year":"2019","unstructured":"Rotstein, D. & Montalban, X. Reaching an evidence-based prognosis for personalized treatment of multiple sclerosis. Nat. Rev. Neurol. 15, 287\u2013300. https:\/\/doi.org\/10.1038\/s41582-019-0170-8 (2019).","journal-title":"Nat. Rev. Neurol."},{"key":"22266_CR23","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/s11845-020-02377-2","volume":"190","author":"P Yigit","year":"2021","unstructured":"Yigit, P., Acikgoz, A., Mehdiyev, Z., Dayi, A. & Ozakbas The relationship between cognition, depression, fatigue, and disability in patients with multiple sclerosis. Ir. J. Med. Sci. 190, 1129\u20131136. https:\/\/doi.org\/10.1007\/s11845-020-02377-2 (2021).","journal-title":"Ir. J. Med. Sci."},{"key":"22266_CR24","doi-asserted-by":"publisher","first-page":"106151","DOI":"10.1016\/j.msard.2024.106151","volume":"92","author":"S Jette","year":"2024","unstructured":"Jette, S., de Schaetzen, C., Tsai, C. C. & Tremlett, H. The multiple sclerosis gut Microbiome and disease activity: A systematic review. Mult Scler. Relat. Disord. 92, 106151. https:\/\/doi.org\/10.1016\/j.msard.2024.106151 (2024).","journal-title":"Mult Scler. Relat. Disord"},{"key":"22266_CR25","doi-asserted-by":"publisher","first-page":"7786","DOI":"10.1038\/s41598-024-57949-4","volume":"14","author":"L Boussamet","year":"2024","unstructured":"Boussamet, L. et al. Investigating the metabolite signature of an altered oral microbiota as a discriminant factor for multiple sclerosis: a pilot study. Sci. Rep. 14, 7786. https:\/\/doi.org\/10.1038\/s41598-024-57949-4 (2024).","journal-title":"Sci. Rep."},{"key":"22266_CR26","doi-asserted-by":"publisher","first-page":"108402","DOI":"10.1016\/j.intimp.2021.108402","volume":"102","author":"SPD Berry","year":"2022","unstructured":"Berry, S. P. D. et al. The role of IL-17 and anti-IL-17 agents in the Immunopathogenesis and management of autoimmune and inflammatory diseases. Int. Immunopharmacol. 102, 108402. https:\/\/doi.org\/10.1016\/j.intimp.2021.108402 (2022).","journal-title":"Int. Immunopharmacol."},{"key":"22266_CR27","doi-asserted-by":"publisher","first-page":"1987780","DOI":"10.1080\/19490976.2021.1987780","volume":"13","author":"CA Brennan","year":"2021","unstructured":"Brennan, C. A. et al. Fusobacterium nucleatum drives a pro-inflammatory intestinal microenvironment through metabolite receptor-dependent modulation of IL-17 expression. Gut Microbes. 13, 1987780. https:\/\/doi.org\/10.1080\/19490976.2021.1987780 (2021).","journal-title":"Gut Microbes"},{"key":"22266_CR28","doi-asserted-by":"publisher","unstructured":"Sakanaka, A. et al. Fusobacterium nucleatum metabolically integrates commensals and pathogens in oral biofilms. mSystems 7 (e0017022). https:\/\/doi.org\/10.1101\/2021.06.23.449328 (2022).","DOI":"10.1101\/2021.06.23.449328"},{"key":"22266_CR29","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1002\/JPER.17-0531","volume":"89","author":"D Polak","year":"2018","unstructured":"Polak, D., Shmueli, A., Brenner, T. & Shapira, L. Oral infection with P. gingivalis exacerbates autoimmune encephalomyelitis. J. Periodontol. 89, 1461\u20131466. https:\/\/doi.org\/10.1002\/JPER.17-0531 (2018).","journal-title":"J. Periodontol"},{"key":"22266_CR30","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson, A. J. et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 17, 162\u2013173. https:\/\/doi.org\/10.1016\/S1474-4422(17)30470-2 (2018).","journal-title":"Lancet Neurol."},{"key":"22266_CR31","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk, D. M. et al. International consensus diagnostic criteria for neuromyelitis Optica spectrum disorders. Neurology 85, 177\u2013189. https:\/\/doi.org\/10.1212\/WNL.0000000000001729 (2015).","journal-title":"Neurology"},{"key":"22266_CR32","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","volume":"22","author":"B Banwell","year":"2023","unstructured":"Banwell, B. et al. Diagnosis of Myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD panel proposed criteria. Lancet Neurol. 22, 268\u2013282. https:\/\/doi.org\/10.1016\/S1474-4422(22)00431-8 (2023).","journal-title":"Lancet Neurol."},{"key":"22266_CR33","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.neurol.2022.07.004","volume":"178","author":"J Ciron","year":"2022","unstructured":"Ciron, J. et al. Secondary progressive multiple sclerosis: a National consensus paper on diagnostic criteria. Rev. Neurol. (Paris). 178, 1098\u20131104. https:\/\/doi.org\/10.1016\/j.neurol.2022.07.004 (2022).","journal-title":"Rev. Neurol. (Paris)"},{"key":"22266_CR34","doi-asserted-by":"publisher","first-page":"5382","DOI":"10.1007\/s00415-022-11193-w","volume":"269","author":"M Filippi","year":"2022","unstructured":"Filippi, M. et al. Early use of high-efficacy disease-modifying therapies makes the difference in people with multiple sclerosis: an expert opinion. J. Neurol. 269, 5382\u20135394. https:\/\/doi.org\/10.1007\/s00415-022-11193-w (2022).","journal-title":"J. Neurol."},{"key":"22266_CR35","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1128\/JCM.41.2.863-866.2003","volume":"41","author":"A Yoshida","year":"2003","unstructured":"Yoshida, A. et al. Development of a 5\u2019 fluorogenic nuclease-based real-time PCR assay for quantitative detection of Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis. J. Clin. Microbiol. 41, 863\u2013866. https:\/\/doi.org\/10.1128\/JCM.41.2.863-866.2003 (2003).","journal-title":"J. Clin. Microbiol."},{"key":"22266_CR36","doi-asserted-by":"publisher","first-page":"108183","DOI":"10.1016\/j.jstrokecerebrovasdis.2024.108183","volume":"34","author":"S Aoki","year":"2025","unstructured":"Aoki, S. et al. Fusobacterium nucleatum in the oral cavity is associated with cerebral small vessel disease in patients with ischemic stroke. J. Stroke Cerebrovasc. Dis. 34, 108183. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2024.108183 (2025).","journal-title":"J. Stroke Cerebrovasc. Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22266-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22266-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22266-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:03:14Z","timestamp":1762549394000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22266-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["22266"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-22266-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]},"assertion":[{"value":"4 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38316"}}